Orion Biotech Opportunities (Orion Biotech Opportunities) Net Issuance of Preferred Stock : $0.00 Mil (TTM As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Orion Biotech Opportunities Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Orion Biotech Opportunities's net issuance of preferred for the three months ended in Dec. 2022 was $0.00 Mil. The number is 0, which means that Orion Biotech Opportunities has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Orion Biotech Opportunities's net issuance of preferred for the trailing twelve months (TTM) ended in Dec. 2022 was $0.00 Mil.

Orion Biotech Opportunities Net Issuance of Preferred Stock Historical Data

The historical data trend for Orion Biotech Opportunities's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Biotech Opportunities Net Issuance of Preferred Stock Chart

Orion Biotech Opportunities Annual Data

Trend

Dec21

Dec22

Net Issuance of Preferred Stock

Orion Biotech Opportunities Quarterly Data
	Feb21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Net Issuance of Preferred Stock	Get a 7-Day Free Trial			-	-	-	-	-

Orion Biotech Opportunities Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Orion Biotech Opportunities Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Orion Biotech Opportunities's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.